Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: World J Urol

Search In Journal Title:

Abbravation: World Journal of Urology

Search In Journal Abbravation:

Publisher

Springer-Verlag

Search In Publisher:

DOI

10.1016/0144-2449(93)90119-n

Search In DOI:

ISSN

1433-8726

Search In ISSN:
Search In Title Of Papers:

Liver resection for metastatic disease prolongs su

Authors: Michael D Staehler Jessica Kruse Nicolas Haseke Thomas Stadler Alexander Roosen Alexander Karl Christian G Stief Karl W Jauch Christiane J Bruns
Publish Date: 2010/05/04
Volume: 28, Issue: 4, Pages: 543-547
PDF Link

Abstract

Eightyeight patients were identified with liver metastases and indication of surgery between 1995 and 2006 In 68 patients liver resection was performed 20 patients denied surgery and served as comparison group Patients were followed for survivalMedian age was 58 Median amount of liver metastases was 2 range 1–30 Median followup was 26 months range 1–187 In both groups 79 received systemic therapy The 5year overall survival rate OSR5 after metastasectomy was 622 ± 114 SEM with a median survival MS of 142 95 confidence interval CI 115–169 months OSR5 in the control group was 293 ± 220 SEM with a MS of 27 95 CI 16–38 months P = 0003 MS was 155 95 CI 133–175 months with metachronous metastases compared to 29 95 CI 25–33 months in the comparison group P = 0001 Lowgrade primary RCC had a MS of 155 95 CI 123–187 months compared to 29 95 CI 8–50 months without resection P = 00036 Highgrade RCC as well as patients with synchronous metastases did not benefit from surgeryLiver metastasectomy is an independent valuable tool in the treatment of metastatic RCC and significantly prolongs patient’s survival even if further systemic treatment is necessary With the evidence given patients may benefit from liver metastasis resection if technically feasible


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer
  2. Treatment of pediatric urolithiasis: how small is “small enough”?
  3. The effect of a cyclic uniaxial strain on urinary bladder cells
  4. The value of the preoperative 1-h pad test with pessary insertion for predicting the need for a mid-urethral sling following pelvic prolapse surgery: a cohort study
  5. Minimally invasive treatment of renal transplant nephrolithiasis
  6. Improved performance of SPECT-CT In-111 capromab pendetide by correlation with diffusion-weighted magnetic resonance imaging for identifying metastatic pelvic lymphadenopathy in prostate cancer
  7. Which factors affect the hospital re-admission and re-hospitalization after flexible ureterorenoscopy for kidney stone?
  8. The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients
  9. Microbiological outcomes in women with diabetes and untreated asymptomatic bacteriuria
  10. Is multichannel urodynamic assessment necessary before considering a surgical treatment of BPH? Pros and cons
  11. Complications of laparoscopic pyeloplasty
  12. Influence of age on false positive rates of urine-based tumor markers
  13. Phosphodiesterase type 2 distribution in the guinea pig urinary bladder
  14. Changing concepts in the surgery of renal cell carcinoma
  15. Association of polymorphisms in CYP19A1 and CYP3A4 genes with lower urinary tract symptoms, prostate volume, uroflow and PSA in a population-based sample
  16. Reduction in incidence of lymphocele following extraperitoneal radical prostatectomy and pelvic lymph node dissection by bilateral peritoneal fenestration
  17. Should inclusion criteria for active surveillance for low-risk prostate cancer be more stringent? From an interim analysis of PRIAS-JAPAN
  18. How accurate are present risk group assignment tools in penile cancer?
  19. Comparison of retrograde intrarenal surgery, shockwave lithotripsy, and percutaneous nephrolithotomy for treatment of medium-sized radiolucent renal stones
  20. German urologists under national socialism
  21. Adverse effects of drug therapies on male and female sexual function
  22. OnabotulinumtoxinA intradetrusorial injections improve sexual function in female patients affected by multiple sclerosis: preliminary results
  23. Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia
  24. Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia
  25. The influence of obstructive interval on patency rates following microsurgical epididymovasostomy
  26. The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer
  27. 3D Navigo™ versus TRUS-guided prostate biopsy in prostate cancer detection
  28. 3D Navigo™ versus TRUS-guided prostate biopsy in prostate cancer detection
  29. Correlation of endorectal coil magnetic resonance imaging of the prostate with pathologic stage
  30. Impact of dutasteride on nocturia in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): a pooled analysis of three phase III studies
  31. Significance of preoperative PSA velocity in men with low serum PSA and normal DRE
  32. Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study
  33. Adult inguinoscrotal sarcomas: outcome analysis of 21 cases, systematic review of the literature and meta-analysis
  34. Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survival
  35. Evaluation of complications in endoscopic extraperitoneal radical prostatectomy in a modular training programme: a multicentre experience
  36. Health care reform in 2010: transforming the delivery system to improve quality of care
  37. A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms
  38. Robotic kidney transplantation: one year after the beginning
  39. The result of adjuvant chemotherapy for localized pT3 upper urinary tract carcinoma in a multi-institutional study
  40. Clinical outcomes and nadir prostate-specific antigen (PSA) according to initial PSA levels in primary androgen deprivation therapy for metastatic prostate cancer
  41. Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy
  42. Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series
  43. Preoperative sex steroids are significant predictors of early biochemical recurrence after radical prostatectomy
  44. Androgens and prostate cancer

Search Result: